S&P 500
(-0.34%) 5 018.39 points
Dow Jones
(0.23%) 37 903 points
Nasdaq
(-0.33%) 15 605 points
Oil
(0.52%) $79.41
Gas
(1.19%) $1.955
Gold
(0.73%) $2 327.80
Silver
(0.19%) $26.80
Platinum
(1.31%) $967.40
USD/EUR
(0.03%) $0.933
USD/NOK
(-0.02%) $11.03
USD/GBP
(-0.06%) $0.798
USD/RUB
(0.27%) $93.51

के लिए वास्तविक समय के अद्यतन Zoetis Inc [ZOE.DE]

एक्सचेंज: XETRA क्षेत्र: Pharmaceuticals उद्योग: Drug Manufacturers—Specialty & Generic
अंतिम अद्यतन30 Apr 2024 @ 21:05

-1.07% 149.92

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 21:05):

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally...

Stats
आज की मात्रा 975.00
औसत मात्रा 332.00
बाजार मूल्य 68.57B
EPS €0 ( 2024-02-12 )
अगली कमाई की तारीख ( €0 ) 2024-05-22
Last Dividend €0.375 ( 2023-07-20 )
Next Dividend €0 ( N/A )
P/E 31.63
ATR14 €0 (0.00%)

Zoetis Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Zoetis Inc वित्तीय

Annual 2023
राजस्व: €8.54B
सकल लाभ: €5.98B (70.03 %)
EPS: €5.08
FY 2023
राजस्व: €8.54B
सकल लाभ: €5.98B (70.03 %)
EPS: €5.08
FY 2022
राजस्व: €8.08B
सकल लाभ: €5.63B (69.63 %)
EPS: €4.51
FY 2021
राजस्व: €7.78B
सकल लाभ: €5.47B (70.38 %)
EPS: €4.26

Financial Reports:

No articles found.

Zoetis Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0.325
(N/A)
€0.325
(N/A)
€0.375
(N/A)
€0.375
(N/A)
€0.375
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Zoetis Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.75 - Stable (15.08%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.200 2020-01-16
Last Dividend €0.375 2023-07-20
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 15 --
Total Paid Out €4.23 --
Avg. Dividend % Per Year 0.00% --
Score 4.04 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.75
Div. Directional Score 7.96 --
Next Divdend (Est)
(2024-07-01)
€0.390 Estimate 22.50 %
Dividend Stability
0.60 Above Average
Dividend Score
4.04
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
MTE.DE Ex Dividend Junior 2023-07-07 Quarterly 0 0.00%
68V.DE Ex Dividend Knight 2023-08-07 Quarterly 0 0.00%
WAF.DE Ex Dividend Junior 2023-05-08 Annually 0 0.00%
FIE.DE Ex Dividend Junior 2023-07-14 Annually 0 0.00%
PAH3.DE Ex Dividend Knight 2023-07-03 Annually 0 0.00%
AP2.DE Ex Dividend Knight 2023-11-22 Quarterly 0 0.00%
HDI.DE Ex Dividend Knight 2023-08-30 Quarterly 0 0.00%
RWE.DE Ex Dividend Junior 2023-05-05 Annually 0 0.00%
CAR.DE Ex Dividend Knight 2023-06-06 Annually 0 0.00%
KEL.DE Ex Dividend Knight 2023-08-31 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2741.5004.516.77[0 - 0.5]
returnOnAssetsTTM0.1641.2004.535.44[0 - 0.3]
returnOnEquityTTM0.4881.5005.688.53[0.1 - 1]
payoutRatioTTM0.295-1.0007.05-7.05[0 - 1]
currentRatioTTM3.360.80010.008.00[1 - 3]
quickRatioTTM1.7700.8004.303.44[0.8 - 2.5]
cashRatioTTM1.0791.5005.117.67[0.2 - 2]
debtRatioTTM0.473-1.5002.12-3.18[0 - 0.6]
interestCoverageTTM13.611.0006.076.07[3 - 30]
operatingCashFlowPerShareTTM5.112.008.3010.00[0 - 30]
freeCashFlowPerShareTTM3.522.008.2410.00[0 - 20]
debtEquityRatioTTM1.352-1.5004.59-6.89[0 - 2.5]
grossProfitMarginTTM0.7001.0001.6621.662[0.2 - 0.8]
operatingProfitMarginTTM0.3811.0004.394.39[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3481.0009.189.18[0.2 - 2]
assetTurnoverTTM0.5980.8009.357.48[0.5 - 2]
Total Score10.17

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM31.421.0006.930[1 - 100]
returnOnEquityTTM0.4882.507.238.53[0.1 - 1.5]
freeCashFlowPerShareTTM3.522.008.8310.00[0 - 30]
dividendYielPercentageTTM1.0101.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM5.112.008.3010.00[0 - 30]
payoutRatioTTM0.2951.5007.05-7.05[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2751.0005.620[0.1 - 0.5]
Total Score5.75

Zoetis Inc

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं